Otsuka Holdings Co., Ltd. logo

Otsuka Holdings Co., Ltd.

4578.T

JPXHealthcareDrug Manufacturers - General

Latest quote

¥12,210

+¥15.00 · +0.12%

Aug 24, 3:30 PM JST

4578.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.

Industry
Drug Manufacturers - General
Sector
Healthcare
Headquarters
JP
CEO
Makoto Inoue
Listed since
Dec 15, 2010
Employees
37,758

Market position

Day range

Current ¥12,210

52-week range

Current ¥12,210

Open
¥12,295
Previous close
¥12,195
Volume
614.4K
0.48× average
Average volume
1.28M
Average daily volume
Market cap
6.42T JPY
Beta
-0.05
Market reference 1
50-day average
¥11,295.9
+8.09% above average
200-day average
¥10,350.93
+17.96% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.4T JPY
P/E (TTM)
15.89×
P/B (TTM)
1.98×
P/S (TTM)
2.45×
EV / EBITDA
7.19×
Earnings yield
7.72%
Free cash flow yield
6.71%
Dividend yield
1.39%

Profitability & efficiency

Gross margin
71.78%
Operating margin
17.26%
Net margin
15.46%
Return on equity
11.97%
Return on assets
8.65%
Return on invested capital
9.20%

Financial health

Debt / equity
0.06×
Current ratio
2.17×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends78%52%26%-1%Gross margin, FY2021: 66.96%Gross margin, FY2022: 67.23%Gross margin, FY2023: 69.72%Gross margin, FY2024: 71.65%Gross margin, FY2025: 71.68%Operating margin, FY2021: 9.92%Operating margin, FY2022: 8.65%Operating margin, FY2023: 6.92%Operating margin, FY2024: 17.03%Operating margin, FY2025: 16.71%Net margin, FY2021: 8.37%Net margin, FY2022: 7.70%Net margin, FY2023: 6.02%Net margin, FY2024: 14.73%Net margin, FY2025: 14.71%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 66.96%. Gross margin FY2022 67.23%. Gross margin FY2023 69.72%. Gross margin FY2024 71.65%. Gross margin FY2025 71.68%. Operating margin FY2021 9.92%. Operating margin FY2022 8.65%. Operating margin FY2023 6.92%. Operating margin FY2024 17.03%. Operating margin FY2025 16.71%. Net margin FY2021 8.37%. Net margin FY2022 7.70%. Net margin FY2023 6.02%. Net margin FY2024 14.73%. Net margin FY2025 14.71%.

Income trends

Revenue

2.47T JPY+5.97%

Operating income

412.43B JPY+3.93%

Net income

363.15B JPY+5.84%
Income trends across reported periods2.7T JPY1.76T JPY825.8B JPY−113.11B JPYRevenue, FY2021: 1.5T JPYRevenue, FY2022: 1.74T JPYRevenue, FY2023: 2.02T JPYRevenue, FY2024: 2.33T JPYRevenue, FY2025: 2.47T JPYOperating income, FY2021: 148.62B JPYOperating income, FY2022: 150.32B JPYOperating income, FY2023: 139.61B JPYOperating income, FY2024: 396.85B JPYOperating income, FY2025: 412.43B JPYNet income, FY2021: 125.46B JPYNet income, FY2022: 133.91B JPYNet income, FY2023: 121.62B JPYNet income, FY2024: 343.12B JPYNet income, FY2025: 363.15B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.5T JPY. Revenue FY2022 1.74T JPY. Revenue FY2023 2.02T JPY. Revenue FY2024 2.33T JPY. Revenue FY2025 2.47T JPY. Operating income FY2021 148.62B JPY. Operating income FY2022 150.32B JPY. Operating income FY2023 139.61B JPY. Operating income FY2024 396.85B JPY. Operating income FY2025 412.43B JPY. Net income FY2021 125.46B JPY. Net income FY2022 133.91B JPY. Net income FY2023 121.62B JPY. Net income FY2024 343.12B JPY. Net income FY2025 363.15B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue2.47T JPY2.33T JPY2.02T JPY1.74T JPY1.5T JPY
Cost of goods sold699.12B JPY660.43B JPY611.22B JPY569.5B JPY495.03B JPY
Gross profit1.77T JPY1.67T JPY1.41T JPY1.17T JPY1T JPY
Research and development352.84B JPY314.23B JPY307.8B JPY275.23B JPY232.3B JPY
Selling, general, and administrative1T JPY958.35B JPY807.36B JPY724.13B JPY622.33B JPY
Operating expenses1.36T JPY1.27T JPY1.27T JPY1.02T JPY854.63B JPY
Interest income15.7B JPY21.08B JPY9.57B JPY28.69B JPY13.98B JPY
Interest expense27.03B JPY8.79B JPY6.52B JPY6.06B JPY4.84B JPY
Depreciation and amortization116.17B JPY107.98B JPY93.7B JPY93.76B JPY84.86B JPY
Operating income412.43B JPY396.85B JPY139.61B JPY150.32B JPY148.62B JPY
Net income363.15B JPY343.12B JPY121.62B JPY133.91B JPY125.46B JPY

Company facts updated Aug 24, 2026.

4578.T peers

ETFs holding 4578.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 4578.T

research.disclaimer